Related Experiment Video
Updated: Jan 5, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Recent developments and advances in atopic dermatitis and food allergy
Kazunari Sugita1, Cezmi A Akdis2
1Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos Platz, Switzerland; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Tottori University Faculty of Medicine, Yonago, Japan.
Recent advances in atopic dermatitis (AD) and food allergy (FA) focus on molecular mechanisms and precision medicine. Understanding skin barrier defects offers new prevention and treatment strategies for allergic diseases.
Area of Science:
- Immunology
- Dermatology
- Allergy
Background:
- Atopic dermatitis (AD) and food allergy (FA) are complex diseases with significant psychosocial impacts.
- Recent years have seen major advances in understanding the molecular mechanisms and disease endotypes of AD and FA.
- The link between skin barrier defects and allergic diseases like AD, FA, asthma, and inflammatory bowel disease is increasingly recognized.
Purpose of the Study:
- To review recent advances in atopic dermatitis (AD) and food allergy (FA), focusing on molecular mechanisms, disease endotypes, and management strategies.
- To highlight developments in personalized medicine, prevention, and future treatments for AD and FA.
- To discuss the role of skin barrier function in allergic disease development and potential therapeutic targets.
Main Methods:
- Literature review of recent studies (primarily from the last two years) on AD and FA.
- Analysis of molecular mechanisms, genetic associations, and immunological aspects of AD and FA.
- Examination of advancements in diagnostic tools, biomarkers, and therapeutic pipelines.
Main Results:
- Precision medicine approaches for AD are advancing due to a better understanding of pathophysiology.
- Skin barrier gene defects are associated with IgE-mediated FA and suggest novel prevention strategies for type 2 diseases.
- The development of reliable biomarkers is crucial for validating tailored management and targeted therapies for severe AD.
Conclusions:
- A deeper understanding of molecular mechanisms and pathophysiology is essential for developing accurate diagnostic tools and innovative solutions for FA.
- Personalized management of AD requires validated biomarkers for tailored prevention and targeted therapies.
- Advances in understanding skin barrier function offer new therapeutic avenues for AD, FA, and other type 2 allergic diseases.
Related Concept Videos
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Asthma-I: Introduction

